Literature DB >> 18472194

Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting.

Wenjing Li1, Shirui Li, Yu Hu, Bixia Tang, Lianxian Cui, Wei He.   

Abstract

Cytokines are major regulators of the immune response, and have been used as adjuvants to improve vaccine potency. In this study, we investigated the adjuvant effects of interleukin (IL)-15 on improving the immunogenicity of human immunodeficiency virus (HIV)-1 gag DNA vaccine in Balb/c mice. During a 370-day follow-up, cellular and humoral immune responses in three separate cohorts of mice were monitored. These results were exemplified through: lymphocyte proliferation, induction of antigen-specific CD8(+) T lymphocytes, long-term production of specific antibodies, and proportion of differentiated memory CD8(+) T cells. These data revealed that just boost of IL-15 at day 8 after co-immunization induced more homeostatic cell proliferation, augmented proliferation frequency of IFN-gamma-secreting antigen-specific CD8(+) T lymphocytes, maintained the long-lasting humoral immune response and promoted the turnover of memory T cell precursors into central memory T cells. Taken together, our data demonstrated that a single IL-15 boosting can enhance both the humoral and cellular immune responses of the HIV-1 gag DNA vaccination. This novel boosting strategy may facilitate the application of IL-15 as an adjuvant for HIV vaccination.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18472194     DOI: 10.1016/j.vaccine.2008.03.081

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  In vitro sensitization of T cells with DC-associated/delivered HIV constructs can induce a polyfunctional CTL response, memory T-cell response, and virus suppression.

Authors:  Swarali Kurle; Madhuri Thakar; Ashwini Shete; Ramesh Paranjape
Journal:  Viral Immunol       Date:  2012-01-10       Impact factor: 2.257

Review 2.  Technologies for enhanced efficacy of DNA vaccines.

Authors:  Fadi Saade; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

3.  IL-15 increases the frequency of effector memory CD8+ T cells in rhesus monkeys immunized with HIV vaccine.

Authors:  Shirui Li; Xiangrong Qi; Yingying Gao; Yanling Hao; Lianxian Cui; Li Ruan; Wei He
Journal:  Cell Mol Immunol       Date:  2010-09-27       Impact factor: 11.530

4.  Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.

Authors:  Charles H Jones; Anders P Hakansson; Blaine A Pfeifer
Journal:  J Mater Chem B       Date:  2014-09-12       Impact factor: 6.331

Review 5.  Encoded novel forms of HSP70 or a cytolytic protein increase DNA vaccine potency.

Authors:  Tamsin Garrod; Branka Grubor-Bauk; Stanley Yu; Tessa Gargett; Eric J Gowans
Journal:  Hum Vaccin Immunother       Date:  2014-11-19       Impact factor: 3.452

6.  PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice.

Authors:  Jingying Zhou; Allen K L Cheung; Zhiwu Tan; Haibo Wang; Wenbo Yu; Yanhua Du; Yuanxi Kang; Xiaofan Lu; Li Liu; Kwok-Yung Yuen; Zhiwei Chen
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

7.  Plasmid-encoded interleukin-15 receptor alpha enhances specific immune responses induced by a DNA vaccine in vivo.

Authors:  Kimberly A Kraynyak; Michele A Kutzler; Neil J Cisper; Dominick J Laddy; Matthew P Morrow; Thomas A Waldmann; David B Weiner
Journal:  Hum Gene Ther       Date:  2009-10       Impact factor: 5.695

8.  Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44(+)CD62L(high) IL-7R(+) CTLs with up- and downregulation of anti- and pro-apoptosis genes.

Authors:  Rong Wang; Andrew Freywald; Yue Chen; Jianqing Xu; Xin Tan; Jim Xiang
Journal:  Cell Mol Immunol       Date:  2014-09-08       Impact factor: 11.530

9.  Intranasal co-delivery of IL-6 gene enhances the immunogenicity of anti-caries DNA vaccine.

Authors:  Ling-kai Su; Fei Yu; Zhao-fei Li; Chang Zeng; Qing-an Xu; Ming-wen Fan
Journal:  Acta Pharmacol Sin       Date:  2014-05       Impact factor: 6.150

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.